期刊文献+

长期输血患者铁代谢与Hepcidin水平的相关性研究 被引量:5

Correlation study of iron metabolism and hepcidin level in long-term transfusion patients
下载PDF
导出
摘要 目的探讨长期输血患者体内铁代谢与铁调素Hepcidin表达水平的相关性,为临床诊疗和合理安全用血提供依据。方法抽取本院收治的30例肿瘤患者和23例β地中海贫血患者,在其累计输血(RBC)>20 U或10 U(儿童)后抽取静脉血标本进行铁代谢指标(全血铁、转铁蛋白和铁蛋白)与铁调素Hepcidin水平检测,并对检测数据进行相关性分析。结果长期输血导致铁代谢紊乱,患者体内显示铁负荷超载;同时Hepcidin表达水平上升,分析显示不同病种某些铁代谢指标与其存在相关性。结论长期输血患者应充分考虑其体内铁代谢状况,适时做出调节,以达到输血与治疗效果的合理平衡。 Objective To explore the correlation between iron metabolism and expression level of hepcidin in long- term transfusion patients aiming at providing references for clinical diagnosis and treatment, and blood transfusion in safe and reasonable way. Methods Thirty patients with tumor and 23 patients with β-thalassemia admitted into our hospital were selected.After RBC in the accumulative blood transfusion being more than 20 U or 10 U in child,the indexes of iron metabolism like iron in while blood, transferrin, and ferroprotein and expression level of hepcidin were tested by drawing venous blood.The tested data were carried on correlation analysis. Results Long-term blood transfusion led to disorder of iron metabolism displaying iron overload in the body as well as increasing expression level of hepeidin.According to outcomes of analysis,some indexes of iron metabolism in different diseases had statistical correlations with the expression level of hepcidin. Conclusion For long-term blood transfusion patient,it is proper to take the state of iron metabolism in vivo into consideration and make some adjustment in due time so as to realize a reasonable balance between blood transfusion and therapeutic effect.
作者 蒋亮 钟凤朝
出处 《中国当代医药》 2014年第19期18-21,共4页 China Modern Medicine
基金 广东省佛山市顺德区医学科研立项课题(2012097)
关键词 铁代谢 铁调素 输血 肿瘤 地中海贫血 Iron metabolism Hepcidin Blood transfusion Tumor Thalassemia
  • 相关文献

参考文献15

二级参考文献122

  • 1区小冰,张力,余一平,李梅爱,何艳明.基因芯片诊断地中海贫血的研究[J].中华儿科杂志,2005,43(1):31-34. 被引量:33
  • 2潘健涛,朱波,许元文,钟先阳,黄锋先,吴培根,余学清.静脉注射氢氧化铁蔗糖复合物治疗肾性贫血的临床研究和安全性分析[J].中国血液净化,2005,4(1):26-28. 被引量:18
  • 3孟丽娟,李建勇,陆化,吴汉新,吴冠宇,朱雨,刘澎,黄峻.间充质干细胞体外扩增联合自体外周血造血干细胞移植治疗恶性血液病[J].苏州大学学报(医学版),2005,25(2):252-255. 被引量:5
  • 4[1]Martinelli AL,Ranalho LN,Zucoloto AS.Hepatic stellate cells in hepatitis C patients:relationship with liver iron deposits and severity of liver disease[J].J Gastroenterol Hepatol,2004,19(1):91-98
  • 5[2]Toniutto P,Fabris C,Bortolotti N,et al.Evaluation of donor hepatie iron concentration as a factor of early fibrotic progression after liver transplantation[J].J Hepatol,2004,41(2):307-311
  • 6[3]Cohen AR,Glimm E,Porter JB.Effect of transfusional iron intake on response to chelation therapy in β-thalassemia major[J].Blood,2008,111(2):583-587
  • 7[4]Swaminathan S,Fonseca VA,Alam MG,et al.The role of iron in diabetes and its complications[J].Diabetes Care,2007,30(7):1926-1933
  • 8[5]Bartfay WY,Bartfay E.Iron-overload cardiomyopathy:evidence for a free radia 12 mediated mechanism of injury and dysfunction in a murine model[J].Biol Res Nurs,2000,2(1):49-50
  • 9[6]Kattamis A,Dinopoulos A,Ladis V,et al.Variations of ferritin levels over a period of 15 years as a compliance chelation index in thalassemic patients[J].Am J Hematol,2001,68(4):221-224
  • 10[7]Angelucci E,Brittenham GM,Mclaren CE,et al.Hepatic iron concentration and total body iron:stores in thalassemia major[J].N Engl J Med,2000,343(5):327-331

共引文献29

同被引文献68

  • 1徐丽.观察促红细胞生成素、蔗糖铁治疗癌性贫血患者的临床疗效[J].智慧健康,2022,8(27):70-73. 被引量:2
  • 2杨玲辉,施小燕,容劲枝.左卡尼汀联合人重组促红细胞生成素在血液透析肾性贫血患者中的应用[J].透析与人工器官,2022,33(2):31-34. 被引量:2
  • 3Kohgo Y, Ikuta K, Ohtake T, et al. Body iron metabolism and pathophysi- ology of iron overload[ J]. Int J Hemato1,2008 ;88 ( 1 ) :7-15.
  • 4Abetz L, Baladi JF,Jones P, et al. The impact of iron overload and its treatment on quality of life: results from a literature review [ J ]. Health Quality Life Outcomes,2006 ;4( 1 ):73.
  • 5Fujita N, Suqimoto R, Urawa N, et al. Hepatic iron accumulation is asso- ciated with disease progression and resistance to inteffemn/ribavirin com- bination therapy in chronic hepatitis C [ J ]. J Gastroenterol Hepatol, 2007 ;22 ( 11 ) : 1886-93.
  • 6Bacon BR. Hemochromatosis : diagnosis and management[ J]. Gastroenter- ology,2001 ;120(3) :718-25.
  • 7Powell LW. Hereditary hemochmmatosis and iron overload diseases[ J ]. J Gastroenterol Hepato1,2002 ; 17 ( S1 ) : S191-5.
  • 8Hu FB. The iron-heart hypothesis:search for the ironclad evidence [ J ]. JAMA,2007 ;297 (6) :639-41.
  • 9Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. Survival and compli- cations in patients with thalassemia major treatert with transfusion and de- feroxamine [ J ]. Haematologica ,2004 ;89 ( 10 ) : 1187 -93.
  • 10Auer J, Berent R, Weber T,et al. Coronary atherosclerosis and body iron stores[ J]. J Am CoB Cardio1,2003 ;41 (10) : 1848-9.

引证文献5

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部